Cannabis Weekly Round-Up: TMX Shares Update on Doing Business in the US
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
The TSX issued a staff notice where cannabis companies with US interests may not be facing a positive outlook.
Tetra Bio-Pharma signed an agreement deal with Aphria to start promoting a co-developed medical cannabis blend product.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Shelly Kumar
Alternate Health Corp. (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, today announced the rebranding of its CanaCard software to the CanaPass
The Canadian Securities Exchange launched a new index meant to account for the largest companies on the exchange, some of the top weighing companies in the index operate in the cannabis business.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Two of the biggest cannabis producers in Canada respond to the outline Ontario plans to follow on the road to cannabis legalization.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Aphria alongside its partners in the US cannabis space Liberty Health Sciences released a response on Monday regarding the clarification by the TMX Group on regulatory engagement for cannabis companies listed in Canada but with business activities in the US.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
Aphria announced an investment of $11.5 million for Scientus Pharma through a secured convertible debenture.
Nuuvera a global cannabis company focused on looking for opportunities in regulated jurisdictions, closed a deal with Aphria that sees the LP invest in a $2 million common share offering.
Expansions into the US from Canadian cannabis companies offer investors an opportunity to see returns from rapidly adopting pocket markets all over the country, now Aphria is offering an opportunity in the state of Florida with Liberty Health Sciences.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
The introduction of advertising regulations with support from Advertising Standards Canada (ASC) to be adopted in the branding and promotion of cannabis.
INN took the opportunity to discuss the cannabis sector moving in depth with Neal Gilmer, analyst at Haywood Securities.
WeedMD Inc. (TSX-V:WMD), is pleased to announce that it has entered into a Letter of Intent with Tokyo Smoke BrandCo to license Van der Pop, North America’s premium female-focused cannabis brand. The partnership will allow WeedMD to produce and ship Van der Pop’s branded cannabis in Canada to patients registered
The marijuana sector in Canada is heating up, and publicly traded cannabis companies are performing well since entering the scene. Here’s a brief overview of some of the top gainers.
